Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA. Walsh TJ, et al. J Infect Dis. 2003 Jul 15;188(2):305-19. doi: 10.1086/377210. Epub 2003 Jul 9. J Infect Dis. 2003. PMID: 12854088
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Rex JH, et al. Clin Infect Dis. 1997 Feb;24(2):235-47. doi: 10.1093/clinids/24.2.235. Clin Infect Dis. 1997. PMID: 9114154 Review.
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.
Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, Rinaldi M, Walsh TJ. Espinel-Ingroff A, et al. Antimicrob Agents Chemother. 2001 Jun;45(6):1828-35. doi: 10.1128/AAC.45.6.1828-1835.2001. Antimicrob Agents Chemother. 2001. PMID: 11353633 Free PMC article. Clinical Trial.
Antifungal susceptibility testing: practical aspects and current challenges.
Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW. Rex JH, et al. Clin Microbiol Rev. 2001 Oct;14(4):643-58, table of contents. doi: 10.1128/CMR.14.4.643-658.2001. Clin Microbiol Rev. 2001. PMID: 11585779 Free PMC article. Review.
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller M, Rinaldi M, Schell W, Walsh T. Espinel-Ingroff A, et al. J Clin Microbiol. 2005 Oct;43(10):5243-6. doi: 10.1128/JCM.43.10.5243-5246.2005. J Clin Microbiol. 2005. PMID: 16207990 Free PMC article.
177 results